| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |